{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:27:53Z","timestamp":1779308873844,"version":"3.51.4"},"reference-count":44,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>In recent years, the colon has become a hot topic in biopharmaceutical research as several in vitro models of the human colon have been presented. A major focus is on the characterization of the microbiota and its capabilities. The aim of the present study was to further develop the MimiCol, preserving its properties and accelerating data acquisition. Emphasis was placed on the simplicity of its design and easy scalability. To prove the viability of the concept, degradation of sulfasalazine was investigated, and the bacterial composition during the experiment was assessed by 16S rRNA sequencing. The transfer of the experimental conditions to the new model was successful. Commercially available components were implemented in the setup. The model MimiCol3 represented the colon ascendens satisfactorily in its properties regarding volume, pH value, and redox potential. 16S rRNA sequencing led to further insights into the bacterial composition in the vessels. Degradation of sulfasalazine was in good agreement with in vivo data. The new model of the colon ascendens MimiCol3 enabled us to collect more reliable data, as three experiments were conducted simultaneously under the same conditions.<\/jats:p>","DOI":"10.3390\/pharmaceutics14051049","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T08:37:02Z","timestamp":1652431022000},"page":"1049","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An Advanced Bioreactor Simulating Dynamic Physiological Conditions in the Human Ascending Colon: MimiCol3"],"prefix":"10.3390","volume":"14","author":[{"given":"Regine","family":"Beeck","sequence":"first","affiliation":[{"name":"Center of Drug Absorption and Transport, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, D-17489 Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4883-2212","authenticated-orcid":false,"given":"Annemarie","family":"Dols","sequence":"additional","affiliation":[{"name":"Center of Drug Absorption and Transport, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, D-17489 Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Schneider","sequence":"additional","affiliation":[{"name":"Center of Drug Absorption and Transport, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, D-17489 Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariah-Sohreh","family":"Seradj","sequence":"additional","affiliation":[{"name":"Center of Drug Absorption and Transport, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, D-17489 Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Krause","sequence":"additional","affiliation":[{"name":"Center of Drug Absorption and Transport, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, D-17489 Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7368-9839","authenticated-orcid":false,"given":"Philipp","family":"Schick","sequence":"additional","affiliation":[{"name":"Center of Drug Absorption and Transport, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, D-17489 Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-7747","authenticated-orcid":false,"given":"Werner","family":"Weitschies","sequence":"additional","affiliation":[{"name":"Center of Drug Absorption and Transport, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, D-17489 Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Human Microbiome Project Consortium (2012). Structure, Function and Diversity of the Healthy Human Microbiome. Nature, 486, 207\u2013214.","DOI":"10.1038\/nature11234"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"fnaa097","DOI":"10.1093\/femsle\/fnaa097","article-title":"Intestinal fermentation in vitro models to study food-induced gut microbiota shift: An updated review","volume":"367","author":"Nissen","year":"2020","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2018.06.021","article-title":"Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives","volume":"146","author":"Kotla","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/07853899009147240","article-title":"Intestinal microflora: Metabolism of drugs and carcinogens","volume":"22","author":"Goldin","year":"1990","journal-title":"Ann. Med."},{"key":"ref_6","first-page":"163","article-title":"Colon specific drug delivery systems: A review on various pharmaceutical approaches","volume":"2","author":"Prasanth","year":"2012","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_7","first-page":"451","article-title":"Metabolism of foreign compounds by gastrointestinal microorganisms","volume":"25","author":"Scheline","year":"1973","journal-title":"Pharmacol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00228615","article-title":"Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem","volume":"39","author":"Molly","year":"1993","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/026119299502300205","article-title":"A Multicompartmental Dynamic Computer- controlled Model Simulating the Stomach and Small Intestine","volume":"23","author":"Minekus","year":"1995","journal-title":"Altern. Lab. Anim."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s002530051622","article-title":"A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products","volume":"53","author":"Minekus","year":"1999","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002489900072","article-title":"Validation of a Three-Stage Compound Continuous Culture System for Investigating the Effect of Retention Time on the Ecology and Metabolism of Bacteria in the Human Colon","volume":"35","author":"Macfarlane","year":"1998","journal-title":"Microb. Ecol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wahlgren, M., Axenstrand, M., H\u00e5kansson, \u00c5., Marefati, A., and Pedersen, B.L. (2019). In vitro methods to study colon release: State of the art and an outlook on new strategies for better in-vitro biorelevant release media. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11020095"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Garcia, M.A., Varum, F., Al-Gousous, J., Hofmann, M., Page, S., and Langguth, P. (2022). In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14020291"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"120704","DOI":"10.1016\/j.ijpharm.2021.120704","article-title":"Mimicking the dynamic Colonic microbiota in vitro to gain a better understanding on the in vivo metabolism of xenobiotics: Degradation of sulfasalazine","volume":"603","author":"Beeck","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/jps.24274","article-title":"Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap System","volume":"104","author":"Koziolek","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10611860410001693751","article-title":"In-vitro and in-vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery","volume":"12","author":"Takka","year":"2004","journal-title":"J. Drug Target."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2007.10.026","article-title":"Biorelevant dissolution testing of colon-specific delivery systems activated by colonic microflora","volume":"125","author":"Yang","year":"2008","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1099\/00222615-4-4-451","article-title":"Intestinal Bacteria and the Hydrolysis of Glycosidic Bonds","volume":"4","author":"Haksworth","year":"1971","journal-title":"J. Med. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/S0142-9612(02)00011-X","article-title":"In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents","volume":"23","author":"Zhang","year":"2002","journal-title":"Biomaterials"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejps.2009.03.014","article-title":"Novel polymeric film coatings for colon targeting: Drug release from coated pellets","volume":"37","author":"Karrout","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1469-0691.2008.02070.x","article-title":"Then and now: Use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories","volume":"14","author":"Woo","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Dieterich, W., Schink, M., and Zopf, Y. (2018). Microbiota in the Gastrointestinal Tract. Med. Sci., 6.","DOI":"10.3390\/medsci6040116"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yang, X., Xie, L., Li, Y., and Wei, C. (2009). More than 9,000,000 unique genes in human gut bacterial community: Estimating gene numbers inside a human body. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006074"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00006231-199306000-00012","article-title":"Noninvasive measurement of human ascending colon volume","volume":"14","author":"Badley","year":"1993","journal-title":"Nucl. Med. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2015.10.022","article-title":"Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies","volume":"220","author":"Koziolek","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2672.1991.tb02739.x","article-title":"The control and consequences of bacterial fermentation in the human colon","volume":"70","author":"Cummings","year":"1991","journal-title":"J. Appl. Bacteriol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CMR.17.4.840-862.2004","article-title":"Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases","volume":"17","author":"Clarridge","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/ng.3695","article-title":"Genome-wide association analysis identifies variation in Vitamin D receptor and other host factors influencing the gut microbiota","volume":"48","author":"Wang","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gutjnl-2020-322753","article-title":"Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function","volume":"70","author":"Frost","year":"2021","journal-title":"Gut"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.07.009","article-title":"The gastrointestinal microbiota as a site for the biotransformation of drugs","volume":"363","author":"Sousa","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2672.1960.tb00188.x","article-title":"A readily prepared medium for the cultivation of the lactobacilli","volume":"23","author":"Rogosa","year":"1960","journal-title":"J. Appl. Bacteriol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ajcn\/31.10.S33","article-title":"Some current concepts in intestinal bacteriology","volume":"31","author":"Moore","year":"1978","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1128\/AEM.67.10.4939-4942.2001","article-title":"Comparative Study of Bacterial Groups within the Human Cecal and Fecal Microbiota","volume":"67","author":"Marteau","year":"2001","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jam.13399","article-title":"Aerobic metabolism in the genus Lactobacillus: Impact on stress response and potential applications in the food industry","volume":"122","author":"Zotta","year":"2017","journal-title":"J. Appl. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1128\/am.27.6.1098-1104.1974","article-title":"Effect of Culture Medium and Carbon Dioxide Concentration on Growth of Anaerobic Bacteria Commonly Encountered in Clinical Specimens","volume":"27","author":"Stalons","year":"1974","journal-title":"Appl. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-101-3-377","article-title":"Sulfasalazine. Pharmacology, clinical use toxicity, and related new drug development","volume":"101","author":"Peppercorn","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2036.2003.01408.x","article-title":"Systematic review: The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis","volume":"17","author":"Sandborn","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/1529-0131(199909)42:9<1927::AID-ANR19>3.0.CO;2-X","article-title":"Treatment with sulfasalazine or sulfapyridine, but not 5-Aminosalicylic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis","volume":"42","author":"Volin","year":"1999","journal-title":"Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jcph.359","article-title":"Targeted adsorption of molecules in the colon with the novel adsorbent-based Medicinal Product, DAV132: A proof of concept study in healthy subjects","volume":"55","author":"Ducher","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2125.1979.tb04723.x","article-title":"A Pharmacological Method of Measuring Mouth Caecal Transit Time in Man","volume":"8","author":"Kennedy","year":"1979","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Broesder, A., Bircan, S.Y., de Waard, A.B., Eissens, A.C., Frijlink, H.W., and Hinrichs, W.L.J. (2021). Formulation and In Vitro Evaluation of Pellets Containing Sulfasalazine and Caffeine to Verify Ileo-Colonic Drug Delivery. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13121985"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0016-5085(86)90574-3","article-title":"Sulfapyridine appearance in plasma after salicylazosulfapyridine. Another simple measure of intestinal transit","volume":"91","author":"Kellow","year":"1986","journal-title":"Gastroenterology"},{"key":"ref_43","first-page":"17","article-title":"Reduction of azo dyes and nitroaromatic compounds by bacterial enzymes from the human intestinal tract","volume":"103","author":"Rafii","year":"1995","journal-title":"Environ. Health Perspect."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1128\/aem.56.7.2146-2151.1990","article-title":"Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora","volume":"56","author":"Rafii","year":"1990","journal-title":"Appl. Environ. Microbiol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/5\/1049\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:10:09Z","timestamp":1760137809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/5\/1049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["pharmaceutics14051049"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14051049","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]}}}